Article
Current advances in the clinical management of Perry syndrome: is there hope for the future?
Expert review of neurotherapeutics - 1 Feb 2026
Chmiela Tomasz, Wszolek Zbigniew K
Abstract excerpt
INTRODUCTION: Perry syndrome (PS) is a rare, inherited neurodegenerative disorder caused by mutations in the DCTN1 gene. It is characterized by parkinsonism, neuropsychiatric symptoms, central hypoventilation, and progressive weight loss, typically leading to a rapid disease course and early death. As genetic testing becomes more widespread, PS is increasingly diagnosed, and its clinical spectrum is expanding....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
